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in patients with chylothorax complicating the results of
an esophageal operation,10 because of the extension of
the operation, involving exposure of the chest,
abdomen, and sometimes also the neck, in patients who
very often are elderly, malnourished, and have respira-
tory and cardiologic concomitant problems. For these
reasons, the debate about the ideal treatment of this
complication remains open between nonoperative and
operative management.9-12 Nonoperative management
with intrapleural drainage and total parenteral nutrition
usually requires several weeks for the chylothorax to
resolve and is frequently unsuccessful; therefore when
reoperation is eventually required, it has to be per-
formed in a compromised patient. Different criteria for
the indication and timing of reoperation have been pro-
posed, including the persistence of the chylous leak for
more than 2 weeks3,9,12-14 or a pleural drainage greater
than 1 L per day for more than 5 days,8,12,15 but there
are no controlled studies to define the best timing for an
P ostoperative chylothorax represents an uncommoncomplication of esophagectomy for cancer that is
responsible for respiratory, metabolic, and immunolog-
ic consequences that may threaten a patient’s life.1,2
Significant progress has recently been made in the non-
operative management of this condition.3-5 However,
morbidity and mortality are still elevated,6-9 especially
Objective: Postoperative chylothorax remains an uncommon but poten-
tially life-threatening complication of esophagectomy for cancer, and the
ideal management is still controversial. The aim of the study was to com-
pare the outcomes of patients treated nonoperatively with those of
patients promptly undergoing reoperation. Methods: From 1980 to 1998,
1787 esophagectomies for esophageal or cardia cancer were performed,
and 19 (1.1%) patients had postoperative chylothorax. We analyzed type
of operation, surgical approach, delay of diagnosis of chylothorax, daily
chest tube output, type of management, major complications, death,
hospital stay, and final outcome. Results: Of the 19 patients with chy-
lothorax, 11 were initially managed nonoperatively (group A): 4 (36%)
patients had spontaneous resolution of chylothorax, and the other 7
required reoperation for the persistence of a high-volume output. There
were three infectious complications and one postoperative death in this
group. No reliable predictive criteria of successful versus unsuccessful
nonoperative management could be found. The 8 most recent patients
underwent early reoperation (group B). All patients recovered, and no
major complications possibly related to chylothorax or hospital deaths
were observed. They were discharged after a median of 22 days (range,
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Reoperation should be performed immediately after the diagnosis is
made to avoid the complications related to nutritional and immunolog-
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operation. Certainly an aggressive treatment is prefer-
able before the patient is severely weakened.
This study reviews our 18-year experience and retro-
spectively compares the outcomes of patients initially
treated nonoperatively with those of patients promptly
undergoing reoperation.
Patients and methods
Since 1980, clinical data from patients with esophageal or
cardia cancer were collected prospectively and electronically
stored according to a standardized protocol. From 1980 to
1998, 1787 patients underwent esophagectomy for
esophageal or cardia cancer. The standard operation consist-
ed of subtotal esophagectomy with two-field lymph node dis-
section through a right thoracotomy and midline laparotomy.
A cervicotomy with total esophagectomy or total pharyngo-
laryngo-esophagectomy was also performed when indicated
by the proximal location of the esophageal tumor. A transhi-
atal esophagectomy was performed in selected patients when
thoracotomy was contraindicated. A chest drain was routine-
ly left in place for at least 4 days in patients undergoing a
transthoracic operation, and a mediastinal drain was left in
place for the same period in patients undergoing a transhiatal
operation. The infrahepatic drain was removed 4 days after
the operation. Transthoracic esophagectomy was performed
on 1273 patients, and transhiatal resection was performed on
464 patients with compromised cardiopulmonary function. In
50 patients other procedures were used.
Chylothorax was suspected in the presence of excessive
(>1000 mL per day) chest or mediastinal output continuing
for more than 2 days and was confirmed by physical and bio-
chemical analysis of the fluid. A computer search in our data-
base was undertaken to identify patients with postoperative
chylothorax.
Duration of the chylous leak was defined as the period
between the operation and the removal of the pleural drain,
which occurred when a constant reduction of pleural output
less than 100 mL per day was obtained. The delay of reoper-
ation was defined as the period between the diagnosis of chy-
lothorax and transthoracic ligation of the thoracic duct.
Nonoperative management consisted of intrapleural
drainage, taking the thoracic drain off of suction in an attempt
to allow the leak to seal, and total parenteral nutrition.
Operative management consisted of right thoracotomy and
ligation of the thoracic duct en bloc, with the azygos vein and
adjacent soft tissue immediately above the diaphragm.15
The χ2 or Fisher exact test was used, as appropriate, for
univariate comparisons, and continuous variables were ana-
lyzed by using the unpaired Student t test. Medians are pre-
sented with the 25th and 75th percentiles.
Results
Postoperative chylothorax developed in 19 (1.1%) of
1787 patients who underwent esophagectomy for carci-
noma of the esophagus or the cardia. There were 15
men and 4 women, with an age range of 27 to 70 years
(median, 57 years). The prevalence of chylothorax in
the 1273 patients operated on through a transthoracic
approach was 1% (n = 13), whereas in the 464 patients
who had a transhiatal esophagectomy, the prevalence
was 1.3% (n = 6; P = .8).
All 13 patients who underwent a transthoracic proce-
dure had excessive output of serous fluid through the
chest drain placed at the time of the operation. Patients
who underwent a transhiatal operation had excessive
drainage through the mediastinal drain in 1 patient,
through cervical and abdominal drains in 4 patients,
and unilateral pleural effusion in 1 patient.
Considering all patients, diagnosis was made after a
median of 4 days (range, 2-15 days) from the opera-
tion. However, the chylous leakage was diagnosed later
in patients undergoing a transhiatal approach and with-
out a thoracic drain because it is more difficult to con-
trol thoracic fluid output. In this group the diagnosis
was made after a median of 7.5 days as opposed to 3
days for patients with a transthoracic approach (P =
.006).
In 11 patients (group A) the initial management con-
sisted of drainage of the chylous leakage and total par-
enteral nutrition without oral intake, balanced salt solu-
tion intravenously to maintain hydration, and
supplement of albumin. Four (36%) of the 11 patients
had spontaneous resolution of chylothorax with this
nonoperative management after a median of 21 days
(25th-75th percentile, 20-28.5 days). There were no
hospital morbidities or mortalities among these
patients, all of whom recovered and were subsequently
discharged after a median of 38 days (25th-75th per-
centile, 27-49.7 days) from the operation. The other 7
patients underwent reoperation because of the persis-
tence of a high-volume output. The median delay of
reoperation was 12 days (25th-75th percentile, 9-13.5
days) after diagnosis of chylothorax, and the pleural
drain was removed after a median of 6 days (25th-75th
percentile, 4.5-6.7 days) after reoperation. Infectious
complications were recorded in 3 (43%) of these 7
patients who underwent reoperation 10, 14, and 18
days after diagnosis of chylothorax. These included
pneumonia in 2 patients, both with sepsis and severe
respiratory failure (1 patient died on postoperative day
38), and urinary tract infection in 1 patient.
Furthermore, another patient had a cervical anastomot-
ic leak 11 days after the first operation.
The 4 patients in group A who underwent successful
nonoperative management and the 7 patients who
underwent reoperation after failure of nonoperative
treatment were comparable in terms of median age (50
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vs 54 years, P = .5), chyle peak flow (34.3 vs 35.5 mL
· kg–1 · d–1, P = 1.08), chylous output per body weight
on postoperative day 1 (13.3 vs 9.5 mL/kg, P = .7) and
postoperative day 7 (15.6 vs 30 mL/kg, P = .3), and
median postoperative hospital stay (38 vs 36 days, P =
1.07). However, the range for reoperation (6-18 days)
of patients (n = 7) was uniformly shorter than the range
for patients (n = 4) attempting spontaneous resolution
of the chylothorax (20-48 days). Because this is a ret-
rospective study, and we did not find any reliable crite-
ria predictive of successful versus unsuccessful nonop-
erative management, it is possible that this may reflect
the more or less aggressive surgical attitude of the dif-
ferent surgeons involved.
The 8 most recent patients (group B) underwent early
reoperation after a median of 2 days (range, 1-3 days)
from the diagnosis of chylothorax. Early thoracic duct
ligation was successful in all patients, and the pleural
drain was removed after a median of 5 days (25th-75th
percentile, 5-7.5 days) from reoperation. No hospital
deaths were observed; however, 2 patients had a pro-
longed hospital stay because of postoperative complica-
tions not related to chylothorax: 1 patient who under-
went pharyngo-laryngo-esophagectomy and total
thyroidectomy plus parathyroidectomy had a severe and
persistent hypocalcemia, and the other had ischemic
partial necrosis of the pulled-up stomach. All patients
were discharged after a median of 22 days (25th-75th
percentile, 18.5-33.7 days) from the first operation.
The 11 patients in group A who initially received
nonoperative management and the 8 patients in group
B who underwent early reoperation were comparable
in terms of median age (54 vs 60 years; P = .1), chyle
peak flow (35.5 vs 32.6 mL · kg–1 · d–1, P = .8), post-
operative infectious complications (27% vs 0%, P =
.2), and hospital mortality rates (9% vs 0%, P = 1.0).
On the other hand, a significantly greater number of
units of albumin (10 g/U) and fresh frozen plasma (250
mL/U) were infused in patients of group A (29 units;
25th-75th percentile, 22.5-38.5 units) than in patients
of group B (8 units; 25th-75th percentile, 7.5-18.7
units; P = .005). After the first operation, the thoracic
drain was removed significantly earlier in patients of
group B (median, 14 days; 25th-75th percentile, 12-15
days) than in patients of group A (median, 20.5 days;
25th-75th percentile, 19.2-27.2 days; P = .0007).
Furthermore, although the overall median hospital stay
was not significantly shorter in patients of group B (22
days; 25th-75th percentile, 18.5-33.7 days) than in
patients of group A (36 days; 25th-75th percentile, 26-
51.5 days; P = .1), excluding the 2 patients of group B
with a prolonged hospital stay because of postoperative
complications not related to chylothorax, the median
hospital stay (20.5 days; 25th-75th percentile, 15.5-
22.5 days) was significantly shorter than in patients of
group A (P = .007). 
Findings at the time of reoperation for chylothorax
included injury to the main thoracic duct in 6 patients,
injury to collateral lymphatic vessels in 2 patients, and
no detectable sites of leakage in 7 patients. All patients
underwent ligation of the thoracic duct en bloc, with
the azygos vein and adjacent soft tissue immediately
above the hiatus of the diaphragm and chylothorax
resolved in all the cases.
Discussion
Postoperative chylothorax is a rare but potentially life-
threatening complication of esophagectomy for cancer.
A chylous leak results in important fluid loss and con-
tinued decrease of serum levels of albumin and total pro-
teins and leads to a significant reduction in peripheral
lymphocytes with subsequent impairment of both cell-
mediated immunity and humoral responses.1,16
In our experience the incidence of this complication
has been 1.1%, which is in agreement with results from
other series (Table I).6,8,13,17-19 Differently from Bolger
and associates,6 we found no significant difference in
the prevalence of chylothorax after transthoracic and
transhiatal esophagectomy (1% vs 1.3%).
The diagnosis of chylothorax may be difficult in a
fasting patient because the characteristic milky appear-
ance of the chyle may be absent in the pleural fluid.
Different techniques have been proposed for an early
diagnosis, such as administration of butter or cream8 or
methylene blue20 through the nasogastric tube or
jejunostomy and physical and chemical analysis of the
pleural fluid. At times, lipoprotein analyses that assess
the presence of chylomicrons may be required for the
diagnosis.21
There is considerable controversy concerning the
management of chylothorax. Some authors defend a
nonoperative approach,22 and others advocate early
reoperation.8,10,11,23,24 The reported mortality rate for
chylothorax after an esophageal cancer operation may
be as high as 50% with nonoperative management6,7
because these patients are unable to tolerate a depletion
of nutritional reserves because their conditions are
often severely compromised even before operation.
The surgical treatment was first proposed by
Lampson25 in 1948 and then supported by Goorwitch26
in 1955, and now it has gained greater support, espe-
cially in the treatment of refractory chylothorax. The
first aim of surgical therapy is to relieve respiratory
embarrassment, draining the chyle from the pleural
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space, and to heal the fistula, but the correct timing for
reoperation is not well defined. Recently, Dugue and
associates18 proposed the ratio of chylous output to
body weight on the 5th day after the onset of chylotho-
rax as a parameter of success of nonoperative treat-
ment. In our experience this parameter was not predic-
tive of the evolution of chylothorax, not even after 7
days from the onset of chylothorax. Because it is very
difficult to predict whether a chylous leak would spon-
taneously heal, we think that the treatment must be
prompt and aggressive to prevent the progressive weak-
ening of the patient, which may decrease the chance of
surviving this complication. This aggressive attitude
has the advantages that we reoperate in a pleural space
that is still free from adhesions, which makes it easier
to identify the site of the chylous leak, and that the
patient is not severely impaired by prolonged fluid,
proteins, albumin, and lymphocyte loss. An aggressive
approach was successful in our patients, and the chest
drain could be removed within a few days. Reoperation
took less than 1 hour to complete, and therefore it was
well tolerated also by patients who had undergone a
transhiatal esophagectomy because of limited respira-
tory reserve. The only infectious complications and the
only death that we observed occurred in those patients
who underwent reoperation after a prolonged period of
nonoperative therapy. A recent study from the Mayo
Clinic supports our attitude, strongly recommending
early reoperation.10 In fact, 24 (89%) of the 27 patients
who had chylothorax after an esophageal operation and
who initially underwent nonoperative therapy eventual-
ly required reoperation.
Recently it has been reported19,22,27-29 that video-
assisted thoracoscopic surgical techniques may repre-
sent a good alternative to thoracotomy in the treatment
of chylothorax. This technique offers the advantage of
an easier access to the entire pleural cavity without the
potential morbidity of thoracotomy. 
To prevent postoperative chylothorax, since 1998 we
have routinely ligated the thoracic duct en bloc, with
the azygos vein immediately above the diaphragm dur-
ing transthoracic esophagectomy, and no chylothorax
has developed in the last 106 consecutive patients.
In conclusion, early reoperation with thoracic duct
ligation is the treatment of choice for chylothorax
occurring after esophagectomy. Early reoperation
should be performed just after the diagnosis of chy-
lothorax is made because at this time the procedure is
better tolerated by the patient without the risk of com-
plications that may be related to nutritional and
immunologic depletion.
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